OptiScan Biomedical Corporation develops glucose monitoring systems for the intensive care unit (ICU)/CCU. It offers OptiScanner, an automated, bedside glucose monitoring system to assist healthcare providers manage the glucose level of critically ill patients. The company’s OptiScanner provides serial blood glucose measurements for a range of glucose concentrations. OptiScan Biomedical Corporation was founded in 1994 and is based in Hayward, California.
Current Team (3)Update
Funding Rounds (3) - $64.8MUpdate
Board Members and Advisors (2)Update
Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life...
Wexford Capital is an investment advisor which boasts $6.5 billion of assets under management.
Venture capital subsidiary
Identifies and invests in new medical technologies and the entrepreneurs developing them to...
21021 Corsair Boulevard
Hayward, CA 94545